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The inhibition of Staphylococcus epidermidis biofilm formation by
vancomycinmodified titanium alloy and implications for the treatment of
periprosthetic infection
Abstract
Peri-prosthetic infections are notoriously difficult to treat as the biomaterial implant is ideal for bacterial
adhesion and biofilm formation, resulting in decreased antibiotic sensitivity. Previously, we reported that
vancomycin covalently attached to a Ti alloy surface (Vanc-Ti) could prevent bacterial colonization. Herein
we examine the effect of this Vanc-Ti surface on Staphylococci epidermidis, a Gram-positive organism prevalent
in orthopaedic infections. By direct colony counting and fluorescent visualization of live bacteria, S.
epidermidis colonization was significantly inhibited on Vanc-Ti implants. In contrast, the gram-negative
organism Escherichia coli readily colonized the Vanc-Ti rod, suggesting retention of antibiotic specificity. By
histochemical and SEM analysis, Vanc-Ti prevented S. epidermidis biofilm formation, even in the presence of
serum. Furthermore, when challenged multiple times with S. epidermidis, Vanc-Ti rods resisted bacterial
colonization. Finally, when S. epidermidis was continuously cultured in the presence of Vanc-Ti, the bacteria
maintained a Vanc sensitivity equivalent to the parent strain. These findings indicate that antibiotic
derivatization of implants can result in a surface that can resist bacterial colonization. This technology holds
great promise for the prevention and treatment of periprosthetic infections.
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a b s t r a c t
Peri-prosthetic infections are notoriously difficult to treat as the biomaterial implant is ideal for bacterial
adhesion and biofilm formation, resulting in decreased antibiotic sensitivity. Previously, we reported that
vancomycin covalently attached to a Ti alloy surface (Vanc-Ti) could prevent bacterial colonization.
Herein we examine the effect of this Vanc-Ti surface on Staphylococci epidermidis, a Gram-positive
organism prevalent in orthopaedic infections. By direct colony counting and fluorescent visualization of
live bacteria, S. epidermidis colonization was significantly inhibited on Vanc-Ti implants. In contrast, the
gram-negative organism Escherichia coli readily colonized the Vanc-Ti rod, suggesting retention of
antibiotic specificity. By histochemical and SEM analysis, Vanc-Ti prevented S. epidermidis biofilm
formation, even in the presence of serum. Furthermore, when challenged multiple times with
S. epidermidis, Vanc-Ti rods resisted bacterial colonization. Finally, when S. epidermidis was continuously
cultured in the presence of Vanc-Ti, the bacteria maintained a Vanc sensitivity equivalent to the parent
strain. These findings indicate that antibiotic derivatization of implants can result in a surface that can
resist bacterial colonization. This technology holds great promise for the prevention and treatment of
periprosthetic infections.
 2008 Elsevier Ltd. All rights reserved.
1. Introduction
Implant surfaces serve as ideal substrates for bacterial coloni-
zation. This colonization often results in periprosthetic infection
(PPI), a condition that leads to destruction of local tissues, patient
disability and morbidity, and on occasion, death [1]. The implant
surface accumulates serum proteins which promote bacterial
adherence and colonization [2], and serves as a critical first step in
the development of PPI. The adherent bacteria synthesize
a complex glycocalyx that enmeshes the bacteria and provides
escape for them from immune surveillance or antibiotic treatment
[3–7]. Currently, PPI treatment requires removal of the contami-
nated implant coupled with extensive bone debridement, excision
of infected tissues and bone, and prolonged antimicrobial treat-
ment [8].
Various antimicrobial materials have been developed to counter
this implant-associated infection. The gold standard for targeted
local delivery of antimicrobial agents is antibiotic-impregnated
bone cement (polymethylmethacrylate – PMMA); other antibiotic-
impregnated biodegradable carriers such as sol–gel coatings [9,10]
and hydrogels [11,12] are under development. The use of antibiotic
loaded PMMA allows delivery of high concentrations of antibiotics
to the affected area without causing systemic toxicity. There are,
however, numerous problems with the current local antibiotic
delivery systems. First, most local antibiotic delivery systems are,
by their nature, targeted to initiate treatment upon implantation,
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with levels of eluted drug remaining high for a well-defined period.
Subsequently, the elution of antibiotics falls below the minimal
inhibitory concentration for a longer period, a situation that could
result in emergence of resistant organisms. Second, the drug
delivery is ineffective in penetrating to the bacteria embedded
within the biofilm on the implant surface. Finally, addition of many
antibiotics to PMMA is not possible as the exothermic reaction
caused by curing of the cement results in heat inactivation of the
drug [13,14].
Attachment of bacteria to the implant surface appears to be the
initial and the most critical step in development of PPI and hence,
we and other investigators have invested extensive efforts to
prevent bacterial adherence. We have previously reported that
covalently bonding antibiotics to a metal implant surface can
inhibit bacterial attachment. This antibiotic-derivatized surface is
stable in the face of Staphylococcus aureus (S. aureus) challenges and
prevents its colonization [15]. In this report, we examine the
effect of this surface on a strain of Staphylococcus epidermidis
(S. epidermidis, ATCC 155), an organism that is prevalent in
orthopaedic infections and notorious for forming biofilms.
Furthermore, we evaluate the ability of this surface to prevent
bacterial colonization in the presence of serum proteins. Results of
the study indicate that derivatization of implant surfaces with
antibiotics may provide a practical approach to inhibiting bacterial
colonization of implants and thereby minimizing PPI.
2. Materials and methods
2.1. Experimental design
Colonization of the surface of vancomycin-modified Ti alloy (Ti90Al6V4) rods
(Vanc-Ti) by S. epidermidis was evaluated. We chose Ti90Al6V4 for these studies as it
is commonly used for manufacturing orthopedic implants. Surface colonization was
measured by determining the numbers of S. epidermidis colony forming units (cfu)
adherent to the rods and by treatment of the surface with a vital stain. In parallel,
S. epidermidis colonization of the surface was visualized using scanning electron
microscopy (SEM), currently the gold standard for biofilm detection. The specificity
of inhibition was evaluated using the gram negative organism E. coli, an organism
that is not sensitive to this antibiotic. Finally, we determined if there was emergence
of resistant strains of S. epidermidis on the Vanc-Ti rods following multiple bacterial
challenges.
2.2. Antibiotic modification of Ti alloy
One mm diameter Ti90Al6V4 wire (Ti alloy, Goodfellow, Cambridge, UK) was
passivated with H2O2/H2SO4 and aminopropylated under argon using 5% (v/v)
aminopropyl-triethoxysilane in anhydrous toluene. It was coupled sequentially with
two Fmoc-[2-(2-amino-ethoxy)-ethoxy]-acetic acid (AEEA) linkers and vancomycin
in the presence of O-(7-azabenzo-triazole-1-yl)-1,1,3,3-tetramethyluronium hexa-
fluorophosphate (HATU); between each addition, deprotection was achieved with
20% piperidine in N,N-dimethylformamide [15–17].
2.3. Evaluation of surface colonization
Control and Vanc-Ti rods (5–10 mm 1 mm) were weighed, sterilized with 70%
EtOH for 15 min, and washed twice with BBL Trypticase Soy Broth (TSB, BD
Bioscience). S. epidermidis ATCC 155 or E. coli DH5a was cultured in TSB,
250 rpm, 37 C, 12–16 h (overnight culture) and diluted to 1104 cfu/ml using a 0.5
McFarland standard, a turbidity standard which is equivalent to 107–108 cfu of
S. aureus (PML Microbiologicals, Wilsonville, OR). To evaluate surface colonization,
0.5 ml of the diluted culture was incubated with rods for 2, 5, 8, 12, or 30 h at 37 C
under static conditions. At each time period, 5 control and 5 Vanc-Ti rods were
removed. Each rod was washed 7 times with phosphate-buffered saline (PBS), to
remove non-adherent bacteria. Two rods were used to determine surface bacterial
adhesion/viability and 3 were used for measurement of numbers of adherent
bacteria. Additionally, 3 control and 3 Vanc-Ti rods per time point were processed
for SEM.
2.4. Effect of serum on microbiocidal activity
Control and Vanc-Ti rods were incubated with complete fetal bovine serum (FBS,
Atlanta Biochemicals) or dH2O statically at 37 C for 24–48 h. Rods were removed
and either fixed with 4% paraformaldehyde for 5 min and immunostained for
fibronectin, or incubated with 1104 cfu/ml S. epidermidis for 24 h and evaluated as
above.
2.5. Determination of biofilm formation
Biofilms were stained with crystal violet using a modification of the method of
O’Toole et al. [18]. Specifically, 0.5 ml (Ci¼ 104 cfu/ml) of S. epidermidis cultures were
statically incubated in 24 well plates containing control or Vanc-Ti rods for 2, 5, or
8 h at 37 C. The medium containing non-adherent bacteria was carefully removed
and Vanc-Ti and control rods moved to fresh wells. These rods were washed 6X with
PBS and then stained, in a new well, with 1 ml of PBS containing 100 ml of 1% (w:v)
crystal violet (Sigma-Aldrich, St. Louis, MO) and incubated for 15 min at room
temperature. The rods in the wells were washed 3 times with PBS and crystal violet
then solubilized by addition of 2 ml of 95% EtOH, with rocking for 15 min; absor-
bance was measured (l¼ 570 nm) using a SPECTRAFluorPlus fluorimeter (Tecan,
Research Triangle Park, NC).
2.6. Rod activity following repeated bacterial challenges
Control or Vanc-Ti rods that had been incubated with S. epidermidis in TSB for
24 h were cleaned by washing with 1% Triton X-100 and 10% sodium lauryl sulfate
(Fisher Scientific) in dH2O for 24 h. They were then washed 5 times with PBS,
sterilized with 70% EtOH for 15 min, and washed twice with TSB. Cleaned rods were
incubated with 1104 cfu/ml S. epidermidis in TSB at 37 C for 24 h. Following
washing 5 times with PBS, the rods were assayed for bacterial adhesion/viability
(first re-challenge). Each re-challenge involved an additional round of washing and
culturing with S. epidermidis as described above.
2.7. Evaluation of development of resistance
S. epidermidis was cultured (Ci¼ 104 cfu/ml) in TSB and incubated with the Vanc-
Ti rods for up to 8 weeks, with TSB replaced every 3–4 days. Weekly, the rods were
removed from the medium, sonicated in TSB to suspend adherent bacteria, and
200 ml plated on agar plates. These colonies were assessed by the Thomas Jefferson
University Clinical Microbiology Labs for resistance using growth on vancomycin
plates (6 mg/ml) as well as the Kirby-Bauer disk diffusion assay.
2.8. Quantitative measure of adherent bacteria
Adherent bacteria were detached by sonication for 10 min in 1 ml TSB, followed
by vortexing for 2 min, using a modification of the method of Barth et al. [19]. Total
numbers of bacteria were determined by serial dilutions on TSB agar plates; the
plates were incubated at 37 C for 24 h, and colonies counted. For detection of slow
growing colonies, those plates exhibiting no growth after 24 h were incubated for an
additional 24 h. Numbers of released bacteria were calculated, based on dilution,
and expressed as a function of rod weight.
2.9. Fluorescent staining of adherent bacteria
To remove non-adherent bacteria, rods were washed 7 times with PBS. These
were stained using the Live/Dead BacLightTM Viability Kit (Invitrogen) for 15 min
to fluorescently label viable bacteria, followed by three PBS washes to remove
nonspecific stain. Fluorescent, adherent bacteria were visualized by confocal laser
microscopy (Olympus Fluoview 300).
2.10. Immunohistological detection of vancomycin and fibronectin
Rods were washed twice with PBS and incubated with a primary antibody
against vancomycin (mouse anti-vancomycin IgG, 1:500, US Biologicals) in PBS 4 C,
2 h. For visualizing fibronectin, after incubation in FBS, rods were fixed with 4%
paraformaldehyde, incubated with rabbit anti-bovine fibronectin IgG (1:500, Invi-
trogen) in PBS, 4 C, 2 h. They were then washed 3 times with PBS, incubated in PBS
for 30 min, and then treated with AlexaFluor 488-coupled donkey anti-rabbit or
anti-mouse IgG (1:500, Invitrogen) in PBS, 1 h, followed by 5 PBS washes and
incubation in PBS for 30 min. Stain was visualized by confocal laser microscopy
(Olympus Fluoview 300).
2.11. Scanning electron microscopy
Vanc-Ti rods were incubated with S. epidermidis for 24 h in TSB. Samples were
washed extensively up to 6 times in PBS and fixed with 2.5% glutaraldehyde in 0.1 mol/L
piperazine-1,4-bis(2-ethanesulfonic acid) buffer (pH 7.4) for 5 min. Following fixation,
the samples were stained with 1% OsO4 in 0.1 mol/L piperazine-1,4-bis(2-etha-
nesulfonic acid) buffer (pH 6.8) for 1 h and then re-stained with 2% uranyl acetate for
1 h. The rods were dehydrated in ethanol and sputter-coated with gold. Surfaces were
visualized using an FEI Strata DB235 focused ion beam SEM (FEI Co, Hillsboro, OR).
2.12. Statistics
Experiments were performed a minimum of 3 independent times using at least
3 randomly chosen samples for each repeat. To establish significance, a one-tailed
Student’s t test was used (*p< 0.05). The results were tested by the Kolmogorov–
Smirnov normality tests.
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3. Results
3.1. S. epidermidis colonization of Vanc-Ti
We first determined if the Vanc-Ti surface resists bacterial
colonization over a 30 h time course (Fig. 1). To visualize bacterial
colonization, we used the Live/Dead Assay in which viable bacteria
stain with the membrane permeable Syto9 dye (green) but exclude
propidium iodide (red); non-viable bacteria show both green and
red staining. After incubation with S. epidermidis ATCC 155, the
control surface evidences abundant fluorescence, indicating
extensive bacterial colonization (Fig. 1A left, top panels). At 8, 12
and 30 h, the intense fluorescence indicates the presence of
bacterial foci, characteristic of biofilm formation. In contrast, when
the Vanc-Ti rods are incubated with S. epidermidis, the fluorescence
is very low at 8, 12 and 30 h (bottom panels), indicating that Vanc-Ti
rods resisted bacterial colonization. Only the green channel was
imaged in these and subsequent pictures as dead cells did not
remain adherent to the surfaces. We also examined the specificity
of the treated surfaces. Vancomycin is active against Gram-positive,
but not Gram-negative organisms. We therefore challenged the
Vanc-Ti rod with a Gram negative organism, E. coli DH5a. E. coli
colonization is abundant on both the control and Vanc-Ti rods and
colonization appeared to increase over time (Fig. 1A, right, top and
bottom panels, respectively).
The number of S. epidermidis adherent to control Ti or Vanc-Ti
rods were then quantified by direct plating. Bacterial numbers
(colony forming units, cfu) are significantly (p< 0.05) lower on the
Vanc-Ti rod than on the control rod at 2 (40% control), 5 (6.2% of
control), 8 (5.5% of control), 12 (6.5% of control), and 30 (0.4% of
control) h (Fig. 1B, left). With E. coli, a Gram negative organism that
is not susceptible to the Gram-positive-specific vancomycin, there
were increased colony counts for both the control and Vanc-Ti rods
with time, with no significant differences in numbers of colonies
(Fig. 1B, right). S. epidermidis colonization is inhibited by Vanc-Ti
where E. coli colonization readily occurred, indicating that the
antibacterial properties of the surface duplicate the specificity of
vancomycin, i.e., gram positive bacteria are susceptible whereas
gram negative bacteria are not. Thus, whether evaluated directly
using the live/dead fluorescence assay or by counting adherent
bacteria, the results of this first study indicate that the Vanc-Ti rods
specifically reduce bacterial adherence of gram positive organisms.
3.2. Biofilm formation on Vanc-Ti
The results described above suggested that Vanc-Ti, at the least,
inhibited S. epidermidis adhesion. To learn if the antibiotic pre-
vented biofilm formation, the rods were stained with crystal violet
(Fig. 2A). Predictably, the stain on the control rods increases with
time. These data suggested that the S. epidermidis adherent to the
control rod have started to secrete a matrix; the Vanc-Ti rods show
little evidence of matrix formation. Between 2 and 5 h and between
5 and 8 h, significant increases in crystal violet staining is evident
on the control rods. This elevated level of crystal violet incorpora-
tion is maintained up to 12 h; after this time, there is a decline,
presumably due to normal bacterial death in the now-established
Fig. 1. Bacterial colonization of Vanc-Ti surfaces. Control and Vanc-Ti rods were challenged for 30 h with S. epidermidis, a gram positive organism that falls within the spectrum of
activity of vancomycin, or E. coli, a gram negative organism that is not sensitive to vancomycin and hence tests whether the derivatized Vanc-Ti shows the same activity as the
parent Vanc. Viable, adherent bacteria were fluorescently stained with the Live/Dead reagent and live cells imaged. (A). S. epidermidis: Control surfaces show abundant bacterial
colonization, with extensive fluorescence across the surface at all time points. At early time points, the fluorescence is diffuse; compact areas of intense fluorescence are seen after
8 h. In contrast, the vancomycin-modified surface (Vanc-Ti) shows minimal fluorescence at all time intervals, indicating inhibition of bacterial colonization and biofilm formation in
keeping with the known activities of Vanc. E. coli: On both the Vanc-Ti and the control surface, accumulation of adherent E. coli initiated after w8 h, which gradually increased
during the subsequent 30 h, suggesting that the Vanc-Ti surface retained the selectivity of Vanc against Gram positive, but not Gram negative organisms. Magnification:
bar¼ 200 mm. (B). Adherent bacteria were removed from the rods by sonication and plated for cell counts. S. aureus: When normalized to the counts from the control rod for each
time point, Vanc-Ti rods shows greatly decreased colonization with significant differences at all time points. By 30 h, Vanc-Ti counts are only 0.4% of control compared to 2 h where
they were 40% of control. E. coli: There were no significant differences in the numbers of bacteria retrieved from the control and the Vanc-Ti rods, with large numbers of adherent
bacteria only apparent after 8 h. The actual counts (cfu S.E.M.) are shown below each bar of the histogram (* Significantly different from control. p< 0.05). For each test, the
Vanc-Ti rod inhibited S. epidermidis but not E. coli colonization, suggesting that the Vanc-Ti activity was due to the presence of Vanc. [For interpretation of the references to colour in
this figure legend, the reader is referred to the web version of this article.]
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biofilm [3–7]. At all time points, however, crystal violet staining of
the Vanc-Ti rods is significantly lower than the control rods. In fact,
at the end of the 30 h incubation period, crystal violet incorporation
on the Vanc-Ti surface approaches zero, indicating that the Vanc-Ti
surface significantly prevents biofilm formation.
SEM was used to further examine biofilm formation on Vanc-Ti
rods that had been incubated with S. epidermidis for 24 h (Fig. 2B,
C). The surface displayed an overall roughness due to the presence
of small pits; some smoothening is seen when the vancomycin is
covalently attached to the Ti alloy. After colonization with S. epi-
dermidis, the control surface displays multiple small, spherical
bacteria (diameter z 0.3–1 mm) of a size consistent with the
Staphylococci and that conglomerate in grapelike clusters that are
characteristic of Staphylococci (Fig. 2B). Importantly, the clustering
and the appearance of multiple, small protrusions on the bacteria
are consistent with initiation of slime/glycocalyx formation. In
contrast to the control surface, the Vanc-Ti surface (Fig. 2C) displays
only isolated individual bacteria; the absence of clustering lends
strength to the notion that biofilm is not formed on the Vanc-Ti
surface.
3.3. Multiple S. epidermidis challenges of Vanc-Ti
Since an implant must maintain anti-bacterial activity in the
face of multiple bacterial challenges, we evaluated colonization
following seven separate cycles of a 24 h exposure to S. epidermidis
(Fig. 3). After each cycle of cleaning and re-exposure to bacteria, the
control rods continue to exhibit high live/dead fluorescence as
evidenced by measurement of fluorescent area (Fig. 3A), with the
direct observation of adherent bacteria shown in Fig. 3B. When the
rod fluorescence was quantified by densitometry (Fig. 3A, controls
set to 100%), throughout the first 4 cycles of repeat challenges,
Vanc-Ti rods retain their ability to resist colonization. After 5 cycles,
both the control and Vanc-Ti rods show a low level of variability in
the extent of colonization. By observation, the control rods showed
abundant fluorescence, indicative of abundant colonization (Fig. 3B,
top panel). In contrast, the Vanc-Ti rods show a low level of fluo-
rescence and hence minimal colonization (Fig. 3B, bottom panel).
The results support the contention that the Vanc-Ti rods retain
their activity in the face of multiple challenge exceptionally large
initial numbers (>107 cfu) of S. epidermidis.
3.4. Vanc-Ti activity after serum coverage
We next determined if the antibiotic would remain effective
after incubation with serum proteins (Fig. 4). Incubation in FBS
causes deposition of fibronectin on the control and Vanc-Ti rods;
fibronectin staining is absent from rods that had not been exposed
to serum (Fig. 4A, left). When the rods were probed for vancomycin
coverage using immunofluorescence, abundant fluorescence is
Fig. 2. Biofilm formation on Vanc-Ti surfaces. (A) Absorption of crystal violet was used as an indicator of biofilm formation by S. epidermidis. The relative absorption of the crystal
violet value was normalized to the 2 h control. Control surfaces consistently showed significantly more crystal violet incorporation than the Vanc-Ti surfaces. At 8 and 12 h, crystal
violet incorporation achieved maximum values on the control surfaces, while the Vanc-Ti surface showed no change in staining intensity with time. The absorbance values of the
crystal violet are shown below each bar of the histogram. The absorbance values on the Vanc-Ti rods were near baseline values, indicating no biofilm formation. (* p< 0.05). SEM
analysis: Twenty-four hours after a challenge with S. epidermidis, Vanc-Ti and control rods were imaged by SEM. Both surfaces were passivated in order to achieve similar levels of
surface activation. Control surfaces show extensive colonization by round staphylococci encased in a matrix that suggests biofilm formation (B). In contrast, the Vanc-Ti surface is
devoid of such colonization, with a few single bacterial-like particles observed (C). Magnification: bar¼ 5 mm.
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observed over the surface of the Vanc-Ti rods exposed to FBS;
control rods show no detectable fluorescence (Fig. 4A, right).
Consequently, extensive coating with serum protein does not mask
the ability of the covalently-tethered vancomycin to bind antibody.
To learn if serum proteins affect the antibacterial activity of the
surfaces, the rods were challenged with S. epidermidis (Ci¼ 104 cfu/
ml) for 24 h. Abundant bacterial colonization is observed on the
control rods, regardless of pre-incubation in dH2O or FBS (Fig. 4B).
Importantly, Vanc-Ti rods show minimum bacterial colonization,
independent of surface serum absorption.
3.5. Bacterial susceptibility after Vanc-Ti incubation
Finally, we determined if continuous exposure of S. epidermidis
to the Vanc-Ti rods, in vitro, would foster emergence of resistant
bacteria. After 8 weeks of continuous exposure to control or Vanc-Ti
surfaces, both planktonic and adherent bacteria were assessed for
vancomycin sensitivity. Bacteria incubated under these conditions
fail to grow (24–64 h assessment) on bacterial plates containing
6 mg/ml vancomycin, indicating that MIC for vancomycin for these
bacteria is below 6 mg/ml. These bacterial samples were then
further characterized using the Kirby-Bauer disk diffusion assay
[20,21]. Strains derived from control rods exhibit a zone of inhibi-
tion of 17.69 0.26 mm, whereas those derived from Vanc-Ti rods
showed a zone of 17.59 0.42 mm. Importantly, no stray colonies
grew in the cleared zones.
4. Discussion
Implant-associated, periprosthetic infections pose immense
challenges to the medical community and imparts a huge economic
burden on society. The ability of microorganisms to colonize
implant surfaces and form biofilms is the critical step in the initi-
ation of PPI. Once encased in a biofilm, bacteria become recalcitrant
to immune surveillance and antibiotic therapy is of limited value.
Herein, we address this problem by reporting that modifications of
the Ti alloy surface with covalently tethered vancomycin is
protective against both bacterial adhesion and biofilm formation by
S. epidermidis. This organism together with S. aureus account for
over 90% of implant-associated infections, and because of the
avidity with which S. epidermidis forms biofilms, it is especially
difficult to eradicate [22–25]. We show that S. epidermidis readily
colonizes Ti alloy rods and forms a biofilm. When these rods are
covalently derivatized with vancomycin, colonization is inhibited
and biofilm formation is minimized. Remarkably, inhibition is
maintained in the face of multiple challenges with bacteria in
numbers that far exceed those encountered in vivo, and adsorbed
serum proteins do not alter the activity of the tethered antibiotic.
Together these in vitro studies suggest that we have prepared
a novel surface that exhibits sustained activity against a major
pathogen and that activity is maintained without fostering emer-
gence of resistant bacterial strains.
We monitored biocidal activities of the Vanc-Ti surface using
a number of different techniques: S. epidermidis viability, adhesion,
biofilm formation, SEM and microbiological counting. The use of
crystal violet, an agent that is retained in the secreted glycocalyx
and reacts with peptidoglycans and teichoic acids, provided useful
insight into biofilm formation. The observation that there was an
elevation in the crystal violet retention with time indicated that
S. epidermidis was not merely adhering to the Ti surface but
synthesizing a protective biofilm. The fact that crystal violet
absorption did not appreciably increase after 12 h reflected early
Fig. 3. Antibacterial activity of Vanc-Ti rods following multiple challenges. Control and Vanc-Ti surfaces were incubated with bacteria for 24 h, stripped by detergent lysis, imaged,
and re-incubated with bacteria for another 24 h; the cycle was repeated 7 times and bacteria were visualized with the Live/Dead stain. (A) Abundant bacteria (green) colonized the
control surfaces. In contrast, the Vanc-Ti showed minimum bacterial staining, indicative of significant inhibition of bacterial colonization after each cycle. Magnification:
bar¼ 200 mm. (B) The fluorescent area of the rods was measured and normalized to the control area for each challenge. Subsequent to the first 3 independent challenges, the
surfaces show some variability in their response to further cycles of challenge. Values shown are the average S.E. of 3 independent experiments (*Significantly different from
control, p< 0.05). [For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.]
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proliferative activities of the adherent bacteria on the control
surface and probably activation of quorum sensing proteins to form
the stable biofilm [26–28]. A second important indicator of biofilm
formation was microbiological counting. While the latter technique
provided a quantitative estimate of the number of viable bacteria,
its use was dependent on the strength of adhesion (a variable
quantity) to the implant surface and the ability to completely
transfer and adequately sample the transported bacteria. Despite
these drawbacks, the bacterial number was significantly lower on
the Vanc-Ti surface than the controls at all times sampled. Note-
worthy, perusal of the actual data indicates that there was consid-
erable variation in bacterial counts, especially at long time intervals.
Much of this variation was due to the high bacterial number utilized
for the study. Furthermore, the adherent bacteria on the control
surfaces tended to be associated with biofilms which would
decrease the efficiency of suspension. Any adherent bacteria on the
Vanc-Ti surfaces tended to be in small colonies with limited biofilm
formation, allowing a more efficient suspension of these bacteria.
Therefore, comparisons of the recovered bacteria from control vs.
Vanc-Ti surfaces tended to underestimate differences. Nevertheless
the very large differences in bacterial numbers between the teth-
ered vancomycin and the control rods lend strong direct support to
the contention that the antibiotic retained its biocidal activities and
inhibited biofilm formation, two major events in PPI development.
Cognizant of the fact that PPI probably results from one or more
episodes of exposure to blood-borne organisms, we evaluated the
impact of multiple challenges with S. epidermidis. Using numbers of
organisms that were many orders of magnitude greater than might
be expected in vivo, we found that the Vanc-Ti surface was biocidal
for four or possibly more challenges with S. epidermidis. The fact
that the surface remained active over the 24 h of the challenge and
that re-challenges resulted in continued activity raises interesting
questions about interactions of the geometrically-constrained
antibiotic (i.e., surface-tethered) with the bacterial membrane. As is
the case for the antibiotic in solution, we would hypothesize that
vancomycin was bound reversibly to the Lys-D-Ala-D-Ala pepti-
doglycan that cross linked the bacterial cell wall. After bacteriolysis
occurred, the reversible vancomycin–peptidoglycan interaction
would result in release of any bacterial remnants, leaving the
surface-bound vancomycin free to engage other bacteria. While it is
also likely that some vancomycin was degraded, there were, based
on the data, sufficient numbers of antibiotic molecules tethered to
the Ti surface to maintain a high level of activity as the rod was
assailed with successive rounds of bacterial challenges. Probably,
both the high local concentration of attached antibiotic molecules
together with the reversible nature of the drug–bacteria interaction
would together serve to maintain the activity of the nano-engi-
neered Ti surface.
It could be argued that while the Vanc-Ti surface inhibited
colonization of S. epidermidis, a Gram positive organism, inhibition
was due to alterations in surface charge rather than the presence of
a tethered antibiotic. Indeed, when the surfaces were examined by
SEM, some differences in the topography were seen, mainly
reflecting a small change in overall roughness. This change could
promote bacterial adhesion. To exclude this possibility, we evalu-
ated the effect of the antibiotic on a Gram negative organism, E. coli.
We noted that unlike the studies with S. epidermidis, the Vanc-Ti
surface had minimal effect on E. coli adhesion and bacterial counts.
Thus the Vanc-Ti surface supported E. coli adherence, whereas
S. epidermidis adherence was inhibited. The data strongly suggested
that the tethered vancomycin acts as an antibiotic against a specific
class of organisms and its biocidal properties did not merely reflect
changes in surface structure.
An important final test of the utility of the methodology was the
demonstration that the Vanc-Ti rods did not foster the emergence
of resistant S. epidermidis even after prolonged exposures. Using the
conventional Kirby-Bauer diffusion assay with the CLSI vancomycin
standards[30], our strain of S. epidermidis (ATCC 155) exhibited
a zone of inhibition of w17.6 mm; this was unchanged after 4
weeks of exposure to the Vanc-Ti rods. Furthermore, the absence of
stray colonies in the zones of inhibition indicated that we could
detect no subsets of insensitive or resistant bacteria. Thus, unlike
controlled release systems where decreasing levels of antibiotic can
provide a selective growth advantage, the tethered vancomycin was
stably present at high surface concentrations [29] and therefore
does not confer such an advantage.
5. Conclusions
We have shown that vancomycin covalently tethered to a Ti
alloy surface prevents bacterial colonization and biofilm formation.
Moreover, the tethered antibiotic is stable, maintains its activity
even when challenged multiple times with bacteria and does not
foster resistance. Since S. epidermidis infection is closely linked to
the pathogenesis of PPI, the Vanc-Ti system holds promise of
controlling or even preventing this devastating orthopaedic
condition.
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Fig. 4. Antimicrobial activity of the Vanc-Ti surface in the presence of serum. (A)
Fibronectin adsorption and vancomycin fluorescence. (Left) Control or Vanc-Ti rods were
incubated with FBS for 24 h and fibronectin adsorption detected by immunofluores-
cence analysis. Both surfaces showed abundant fibronectin (red stain), compared to the
rods incubated in H2O. (Right) Following incubation with serum proteins, rods were
incubated with an antibody against vancomycin and visualized by immunofluores-
cence. Despite protein adsorption, vancomycin fluorescence (blue stain) was clearly
detectable on the Vanc-Ti rods, with no staining on control surfaces. (B) Antimicrobial
activity. Vanc-Ti rods that had been treated with serum proteins were challenged with
S. epidermidis for 24 h and live, adherent bacteria stained with the Live/Dead kit
(green). Fluorescence detected from the serum-treated Vanc-Ti rods was very low and
similar to the fluorescence detected from the H2O-incubated Vanc-Ti rods. In both
cases, this fluorescence was much less intense than the fluorescent yield generated by
bacteria that had colonized the control rods. Magnification: bar¼ 200 mm.
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